MedPath

Cancer Research Institute of Contra Costa

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-05-15
Lead Sponsor
Cancer Research Institute of Contra Costa
Registration Number
NCT00007891
Locations
🇺🇸

Cancer Research Institute of Contra Costa, San Francisco, California, United States

🇺🇸

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath